` Comparison: ITRM vs MRK - Alpha Spread

ITRM
vs
MRK

Over the past 12 months, ITRM has underperformed MRK, delivering a return of -79% compared to the MRK's +41% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
ITRM
MRK
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

ITRM Intrinsic Value
0.9467 USD
Undervaluation 70%
Intrinsic Value
Price
MRK Intrinsic Value
113.84 USD
Overvaluation 7%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Iterum Therapeutics PLC
NASDAQ:ITRM
0.2852 USD
Merck & Co Inc
NYSE:MRK
122.06 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
ITRM, MRK

ITRM
MRK
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Iterum Therapeutics PLC
Revenue
Merck & Co Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
ITRM, MRK

ITRM
MRK
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Iterum Therapeutics PLC
NASDAQ:ITRM
Merck & Co Inc
NYSE:MRK
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

ITRM
94.9%
MRK
81.5%

Operating Margin

ITRM
-5 292.3%
MRK
41.2%

Net Margin

ITRM
-6 913.1%
MRK
28.1%

FCF Margin

ITRM
-4 883.1%
MRK
20.1%

ROE

ITRM
278.2%
MRK
37.2%

ROA

ITRM
-111.2%
MRK
14.8%

ROIC

ITRM
-193.2%
MRK
22.5%

ROCE

ITRM
-178.9%
MRK
28.2%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
ITRM, MRK

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
ITRM, MRK

Loading
ITRM
MRK
Difference
www.alphaspread.com

Performance By Year
ITRM, MRK

Loading
ITRM
MRK
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare ITRM to other stocks
LLY
Eli Lilly and Co
JNJ
Johnson & Johnson
ROG
Roche Holding AG
NOVN
Novartis AG
Custom
Choose any stock
Unlock Full Access to Alpha Spread
Create Free Account